BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

PharmaNet Incorporated

PharmaNet is a full-service contract research organization (CRO) dedicated to providing exceptional drug development services on a global basis.



With offices strategically placed throughout the US, Europe and Asia, we provide a complete range of Phase I-IV clinical development services including strategic planning, data management and biostatistics, medical writing, site management and regulatory affairs.



PharmaNet’s innovative use of the latest technologies provides efficiencies within the electronic process from data capture through global electronic regulatory submissions.



Additionally, PharmaNet offers a variety of clinical trial consulting services for all aspects of your pharmaceutical and biotechnology drug development activities including extended services relating to toxicology, chemistry and manufacturing, preclinical and clinical pharmacokinetics and the assessment of in-licensing candidates.


Contact Details:
504 Carnegie Center
Princeton
NJ
08540-6242
United States of America
Tel:609 951 6800
Fax:609 514 0390
Email:lallen@pharmanet-cro.com
WWW:

www.pharmanet-cro.com/




Loading...

Recent Publications by PharmaNet Incorporated:

[Current views on the role of dehydroepiandrosterone in physiology, pathology and therapy]
Dehydroepiandrosterone (DHEA) and its sulfate metabolite (DHEAS) are the...
19th July, 2008
Slaska Akademia Medyczna w Katowicach, Klinika Chorob Wewnetrznych i Pol Merkur Lekarski. 2008 Jan;24(139):66-71.
[Commentary to the article: Wiviott S D, Braunwald E, McCabe C H et al. Prasugrel versus clopidogrel in patients with acute coronary syndromem. N Engl J Med 2007; 357: 2001-15]
Dehydroepiandrosterone (DHEA) and its sulfate metabolite (DHEAS) are the...
19th July, 2008
Samodzielna Pracownia Hemodynamiki, Instytut Kardiologii, Warszawa. Kardiol Pol. 2008 Feb;66(2):222-5; discussion 225-6.
Lack of a significant drug interaction between raltegravir and tenofovir.
Background: Raltegravir is a novel HIV-1 integrase inhibitor with potent...
16th July, 2008
Merck & Co., Inc., Whitehouse Station, New Jersey; Pharmanet Development Antimicrob Agents Chemother. 2008 Jul 14;.
DOI Direct Link
Ghrelin agonist (TZP-101): safety, pharmacokinetics and pharmacodynamic evaluation in healthy volunteers: a phase I, first-in-human study.
The authors evaluate the human safety, tolerability, pharmacokinetics, and...
20th May, 2008
Pharmanet Development Group, Inc., Miami, Florida, USA. J Clin Pharmacol. 2008 Feb;48(2):193-202.
DOI Direct Link
[Somatostatin analogs]
Hypothyroidism is a fairly common disease. The signs and symptoms of...
16th May, 2008
Katedra Farmakologii, Zaklad Farmakologii Klinicznej S1. AM w Katowicach. Pol Arch Med Wewn. 2006 Oct;116(4):988-97.

View more PharmaNet Incorporated research publications.

BioNews Results for PharmaNet Incorporated:

PharmaNet Development Group Restores Credit Line
SmartBrief:  Jul 19 2008 7:55AM Matching: pharmanet
PharmaNet Development Group Restores Credit Line
Pharma Live:  Jul 18 2008 4:42PM Matching: pharmanet
PharmaNet Development Group Restores Credit Line
DiGiTAL50:  Jul 18 2008 7:10AM Matching: pharmanet
PharmaNet Development Group Restores Credit Line
Genetic Engineering News:  Jul 17 2008 10:48PM Matching: pharmanet
PharmaNet Development Group Restores Credit Line
Genetic Engineering News:  Jul 17 2008 10:12PM Matching: pharmanet
Promote your company here: BioNewsCast - Press Release Distribution

View more PharmaNet Incorporated news.

BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 26 individuals from PharmaNet Incorporated using this service.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 343 times since April 2007, the link to the organisation's website has been followed 76 times

Recent Search Terms used to find this page: pharmanet-CRO | pharmanet-CRO | pharmanet-CRO | pharmanet-CRO | pharmanet-CRO | pharmanet | 14th february 2008 contact email addresses managing directors of companies in united state of america | Regulatory medical writing | pharmanet email | .

Search for more companies in Princeton

Search for more companies in NJ



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for PharmaNet Incorporated
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.